No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
1 | Adrenergic signaling in cardiomyocytes 5 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[5] CACNA1C, CACNA1D, CACNA1F, CACNA1S, SCN5A |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
2 | Aldosterone synthesis and secretion 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
3 | Alzheimer disease 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
4 | Amphetamine addiction 6 genes, 2 drugs (DrugBank), 8 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[6] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
5 | Amyotrophic lateral sclerosis (ALS) 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] GRIA1, GRIA2 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
7 | Bile secretion 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] CA2 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
8 | Calcium signaling pathway 7 genes, 3 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[3] HTR2A, HTR2B, HTR2C |
D04148 |
Fenfluramine |
[2] 140, 144 |
D07945 |
9 | cAMP signaling pathway 8 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
10 | Carbohydrate digestion and absorption 1 gene, 2 drugs (DrugBank), 8 diseases shown |
[1] CACNA1D |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
11 | Cardiac muscle contraction 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
12 | Cellular senescence 1 gene, 2 drugs (DrugBank), 8 diseases shown |
[1] CACNA1D |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
13 | cGMP-PKG signaling pathway 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
14 | Cholinergic synapse 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
15 | Circadian entrainment 6 genes, 2 drugs (DrugBank), 8 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[6] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
16 | Cocaine addiction 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] GRIA2 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
17 | Collecting duct acid secretion 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] CA2 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
18 | Cortisol synthesis and secretion 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
19 | Cushing syndrome 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
20 | Dilated cardiomyopathy (DCM) 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
21 | Dopaminergic synapse 7 genes, 2 drugs (DrugBank), 8 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[7] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, SCN1A |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
22 | GABAergic synapse 20 genes, 3 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[20] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D01253 |
Clobazam |
[2] 140, 144 |
23 | Gap junction 3 genes, 1 drug (DrugBank), 2 diseases shown |
[3] HTR2A, HTR2B, HTR2C |
D04148 |
Fenfluramine |
[2] 140, 144 |
D07945 |
24 | Gastric acid secretion 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] CA2 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
25 | Glutamatergic synapse 11 genes, 2 drugs (DrugBank), 8 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[11] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
26 | GnRH secretion 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
27 | GnRH signaling pathway 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
28 | Growth hormone synthesis, secretion and action 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
29 | Hypertrophic cardiomyopathy (HCM) 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
30 | Inflammatory mediator regulation of TRP channels 3 genes, 1 drug (DrugBank), 2 diseases shown |
[3] HTR2A, HTR2B, HTR2C |
D04148 |
Fenfluramine |
[2] 140, 144 |
D07945 |
31 | Insulin secretion 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
32 | Long-term depression 3 genes, 1 drug (DrugBank), 5 diseases shown |
[3] GRIA1, GRIA2, GRIA3 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
33 | Long-term potentiation 3 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] CACNA1C |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[3] CACNA1C, GRIA1, GRIA2 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
34 | MAPK signaling pathway 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
35 | Metabolic pathways 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] CA2, CA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
36 | Morphine addiction 16 genes, 2 drugs (DrugBank), 5 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D01253 |
Clobazam |
[2] 140, 144 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
37 | Neuroactive ligand-receptor interaction 30 genes, 4 drugs (DrugBank), 15 diseases shown |
[2] CNR1, CNR2 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D01253 |
Clobazam |
[2] 140, 144 |
[25] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
[3] HTR2A, HTR2B, HTR2C |
D04148 |
Fenfluramine |
[2] 140, 144 |
D07945 |
38 | Nicotine addiction 20 genes, 2 drugs (DrugBank), 5 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D01253 |
Clobazam |
[2] 140, 144 |
[20] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
39 | Nitrogen metabolism 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] CA2, CA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
40 | Oxytocin signaling pathway 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
41 | Pancreatic secretion 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] CA2 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
42 | Proximal tubule bicarbonate reclamation 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] CA2, CA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
43 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
44 | Renin secretion 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
45 | Retrograde endocannabinoid signaling 25 genes, 4 drugs (DrugBank), 17 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[24] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D01253 |
Clobazam |
[2] 140, 144 |
46 | Serotonergic synapse 11 genes, 4 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[7] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRB1, GABRB2, GABRB3 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
[3] GABRB1, GABRB2, GABRB3 |
D01253 |
Clobazam |
[2] 140, 144 |
[4] HTR2A, HTR2B, HTR2C, SLC6A4 |
D04148 |
Fenfluramine |
[2] 140, 144 |
D07945 |
47 | Synaptic vesicle cycle 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SLC6A4 |
D04148 |
Fenfluramine |
[2] 140, 144 |
D07945 |
48 | Taste transduction 10 genes, 3 drugs (DrugBank), 8 diseases shown |
[1] CACNA1C |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
[10] CACNA1C, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, SCN2A, SCN3A, SCN9A |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D01253 |
Clobazam |
[2] 140, 144 |
49 | Thermogenesis 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
50 | Tight junction 1 gene, 2 drugs (DrugBank), 8 diseases shown |
[1] CACNA1D |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
51 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] GRIA3 |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
52 | Type II diabetes mellitus 2 genes, 2 drugs (DrugBank), 8 diseases shown |
[2] CACNA1C, CACNA1D |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |
53 | Vascular smooth muscle contraction 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
[5] 6, 140, 144, 156, 193 |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
D02356 |